- Min.Order :1 Gram
- Purity: ≥99.5%
- Payment Terms : L/C,D/A,D/P,T/T,,MoneyGram,Other
Keywords
Tofacitinib 540737-29-9 2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
Quick Details
- Appearance:White to quasi-white
- Application:Tolfatinib citrate [540737-29-9] is a drug developed by Pfizer Pharmaceutical Company in the United States for the treatment of rheumatoid arthritis.
- PackAge:Barrel sealed
- ProductionCapacity:1000|Kilogram|Day
- Storage:
- Transportation:
Superiority:
Our company has commercialized this product for long-term stable supply.
Provid：
- MOA
- ROS
- COA
- MSDS
- GMP Standard
- ISO9001:2008 Quality System Certification
Details:
Conpany profile：
Office located in Hightech industrial development zone No. 8, Huangguan Road, Daguan District, Anqing, Anhui Province, 200 workers, more than 10 years experience, Exhibitors of CPhI China 2020, CE & FDA certificate is under the process, will finish in 1 year. Currently we have 16 cooperative companies in Southeast Asia.
Factory profile：
Located in Changzhi, Shanxi including 2500㎡ analysis laboratories equipped with HPLC, GC and other analytical facilities.
One pilot and two mass production workshop with more than 70 glass lined reactors, total reaction capacity can reach 35000L.
Factory profile：
Located in Changzhi, Shanxi including 2500㎡ analysis laboratories equipped with HPLC, GC and other analytical facilities.
One pilot and two mass production workshop with more than 70 glass lined reactors, total reaction capacity can reach 35000L.
Latest main product：
Parecoxib sodium，Brivaracetam，Canagliflozin，Empagliflozin，Dapagliflozin，Tofacitinib，Pimavanserin，Crisaborole，Vonoprazan Fumarate，Tolvaptan ，Febuxostat，Brexpiprazole，Apixaban，Rivaroxaban，Eltrombopag，Ticagrelor，Avatrombopag，Baricitinib，Ruxolitinib，Upadacitinib，Dabigatran，Tavaborole，Finafloxacin Hydrochloride，Topiroxostat
（All products above can be sold in API and intermediates）
Provid：
- MOA
- ROS
- COA
- MSDS
- GMP Standard
- ISO9001:2008 Quality System Certification
Research and provide synthetic process services:
Brivaracetam, Riociguat, Urapidil, Urapidil, Norepinephrine, Empagliflozin, Baricitinib, Upadacitinib, Tavaborole, Finafloxacin, Crisaborole, Ruxolitinib
At the same time, we also provide a full set of services for testing and registering drugs apply to the China National FDA till you get the China National FDA certificate
You Might Also Like
-
Rivaroxaban API & Intermediate
CAS NO:366789-02-8
-
Vonoprazan Fumarate API & Intermediate
CAS NO:1260141-27-2
-
Empagliflozin API & Intermediates
CAS NO:864070-44-0
-
Ruxolitinib API & Intermediates
CAS NO:941678-49-5
-
Crisaborole API & Intermediates
CAS NO:906673-24-3
-
Tofacitinib citrate API & Intermediates
CAS NO:540737-29-9
Related Searches
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View